Cosmo Pharmaceuticals acquires 98.96% stake in BioXell - MarketLine Financial Deals

Cosmo Pharmaceuticals acquires 98.96% stake in BioXell

Cosmo Pharmaceuticals acquires 98.96% stake in BioXell - MarketLine Financial Deals
Cosmo Pharmaceuticals acquires 98.96% stake in BioXell
Published Feb 26, 2010
3 pages — Published Feb 26, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Cosmo Pharmaceuticals S.p.A. has acquired 5,325,713 shares, representing a 98.96% stake, in BioXell S.p.A. through a tender offer.

  
Source:
Document ID
MA13196_091120
Country
Ticker
COPN=IT
Ticker
BXLN=IT
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Cosmo Pharmaceuticals acquires 98.96% stake in BioXell" Feb 26, 2010. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Cosmo-Pharmaceuticals-acquires-98-96-stake-in-BioXell-2052-18039>
  
APA:
MarketLine Financial Deals. (2010). Cosmo Pharmaceuticals acquires 98.96% stake in BioXell Feb 26, 2010. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Cosmo-Pharmaceuticals-acquires-98-96-stake-in-BioXell-2052-18039>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.